Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Innate Pharma SA (NASDAQ:IPHA) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 49.02K a 46.37K. Questo rappresenta il 0.06% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Innate Pharma Corp (XNAS:IPHA) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 12.47K azioni scambiate al giorno, ci vorrebbero 3.72 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
46.37K
Vendite allo scoperto %
0.06%
Giorni di copertura
3.72
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
IPHA | Innate Pharma S.A. ADS | 09/15/2025 | 09/24/2025 | 0.06% | 81,437,908 | 46,368 | 12,466 | 3.72 | |
IPHA | Innate Pharma S.A. ADS | 08/29/2025 | 09/10/2025 | 0.06% | 81,437,908 | 49,023 | 7,861 | 6.24 | |
IPHA | Innate Pharma S.A. ADS | 08/15/2025 | 08/26/2025 | 0.06% | 81,437,258 | 52,047 | 5,223 | 9.96 | |
IPHA | Innate Pharma S.A. ADS | 07/31/2025 | 08/11/2025 | 0.09% | 81,437,258 | 70,228 | 18,096 | 3.88 | |
IPHA | Innate Pharma S.A. ADS | 07/15/2025 | 07/24/2025 | 0.06% | 81,435,958 | 52,005 | 5,632 | 9.23 | |
IPHA | Innate Pharma S.A. ADS | 06/30/2025 | 07/10/2025 | 0.07% | 81,435,958 | 60,667 | 15,688 | 3.87 | |
IPHA | Innate Pharma S.A. ADS | 06/13/2025 | 06/25/2025 | 0.06% | 81,428,808 | 51,456 | 7,944 | 6.48 | |
IPHA | Innate Pharma S.A. ADS | 05/30/2025 | 06/10/2025 | 0.07% | 81,428,808 | 56,217 | 10,655 | 5.28 | |
IPHA | Innate Pharma S.A. ADS | 05/15/2025 | 05/27/2025 | 0.08% | 81,428,808 | 65,673 | 40,465 | 1.62 | |
IPHA | Innate Pharma S.A. ADS | 04/30/2025 | 05/09/2025 | 0.66% | 56,935,283 | 376,067 | 21,425 | 17.55 | |
IPHA | Innate Pharma S.A. ADS | 04/15/2025 | 04/25/2025 | 0.79% | 48,603,971 | 386,047 | 36,247 | 10.65 | |
IPHA | Innate Pharma S.A. ADS | 03/31/2025 | 04/09/2025 | 0.84% | 48,589,896 | 407,251 | 15,652 | 26.02 | |
IPHA | Innate Pharma S.A. ADS | 03/14/2025 | 03/25/2025 | 0.86% | 48,589,896 | 417,095 | 17,014 | 24.51 | |
IPHA | Innate Pharma S.A. ADS | 02/28/2025 | 03/11/2025 | 0.95% | 48,589,896 | 461,383 | 1,435,456 | 1 | |
IPHA | Innate Pharma S.A. ADS | 02/14/2025 | 02/26/2025 | 0.32% | 48,589,896 | 154,180 | 25,274 | 6.1 | |
IPHA | Innate Pharma S.A. ADS | 01/31/2025 | 02/11/2025 | 0.31% | 48,589,896 | 152,458 | 51,670 | 2.95 | |
IPHA | Innate Pharma S.A. ADS | 01/15/2025 | 01/27/2025 | 0.22% | 48,589,896 | 105,426 | 46,080 | 2.29 | |
IPHA | Innate Pharma S.A. ADS | 12/31/2024 | 01/10/2025 | 0.21% | 48,589,896 | 101,041 | 150,827 | 1 | |
IPHA | Innate Pharma S.A. ADS | 12/13/2024 | 12/24/2024 | 1.91% | 47,561,816 | 909,824 | 2,774,442 | 1 | |
IPHA | Innate Pharma S.A. ADS | 11/29/2024 | 12/10/2024 | 0.14% | 45,728,917 | 62,946 | 17,546 | 3.59 | |
IPHA | Innate Pharma S.A. ADS | 11/15/2024 | 11/26/2024 | 0.14% | 45,728,917 | 63,718 | 6,177 | 10.32 | |
IPHA | Innate Pharma S.A. ADS | 10/31/2024 | 11/11/2024 | 0.14% | 45,728,917 | 65,217 | 13,338 | 4.89 | |
IPHA | Innate Pharma S.A. ADS | 10/15/2024 | 10/24/2024 | 0.13% | 45,728,917 | 58,785 | 7,703 | 7.63 | |
IPHA | Innate Pharma S.A. ADS | 09/30/2024 | 10/09/2024 | 0.16% | 45,728,917 | 71,841 | 10,796 | 6.65 | |
IPHA | Innate Pharma S.A. ADS | 09/13/2024 | 09/24/2024 | 0.13% | 45,728,917 | 59,736 | 5,623 | 10.62 | |
IPHA | Innate Pharma S.A. ADS | 08/30/2024 | 09/11/2024 | 0.14% | 45,728,917 | 65,131 | 6,696 | 9.73 | |
IPHA | Innate Pharma S.A. ADS | 08/15/2024 | 08/26/2024 | 0.15% | 45,728,917 | 66,826 | 5,031 | 13.28 | |
IPHA | Innate Pharma S.A. ADS | 07/31/2024 | 08/09/2024 | 0.14% | 45,728,917 | 64,466 | 3,749 | 17.2 | |
IPHA | Innate Pharma S.A. ADS | 07/15/2024 | 07/24/2024 | — | — | 72,858 | 8,751 | 8.33 | |
IPHA | Innate Pharma S.A. ADS | 06/28/2024 | 07/10/2024 | — | — | 69,301 | 12,905 | 5.37 | |
IPHA | Innate Pharma S.A. ADS | 06/14/2024 | 06/26/2024 | — | — | 72,934 | 7,853 | 9.29 | |
IPHA | Innate Pharma S.A. ADS | 05/31/2024 | 06/11/2024 | — | — | 70,004 | 13,579 | 5.16 | |
IPHA | Innate Pharma S.A. ADS | 05/15/2024 | 05/24/2024 | — | — | 70,166 | 3,757 | 18.68 | |
IPHA | Innate Pharma S.A. ADS | 04/30/2024 | 05/09/2024 | — | — | 79,102 | 6,113 | 12.94 | |
IPHA | Innate Pharma S.A. ADS | 04/15/2024 | 04/24/2024 | — | — | 81,275 | 15,432 | 5.27 | |
IPHA | Innate Pharma S.A. ADS | 03/28/2024 | 04/09/2024 | — | — | 76,869 | 10,235 | 7.51 | |
IPHA | Innate Pharma S.A. ADS | 03/15/2024 | 03/26/2024 | — | — | 89,075 | 12,353 | 7.21 | |
IPHA | Innate Pharma S.A. ADS | 02/29/2024 | 03/11/2024 | — | — | 78,358 | 3,939 | 19.89 | |
IPHA | Innate Pharma S.A. ADS | 02/15/2024 | 02/27/2024 | — | — | 82,363 | 7,836 | 10.51 | |
IPHA | Innate Pharma S.A. ADS | 01/31/2024 | 02/09/2024 | — | — | 75,951 | 9,715 | 7.82 | |
IPHA | Innate Pharma S.A. ADS | 01/12/2024 | 01/24/2024 | — | — | 76,672 | 18,925 | 4.05 | |
IPHA | Innate Pharma S.A. ADS | 12/29/2023 | 01/10/2024 | — | — | 84,218 | 66,298 | 1.27 | |
IPHA | Innate Pharma S.A. ADS | 12/15/2023 | 12/27/2023 | — | — | 54,024 | 12,370 | 4.37 | |
IPHA | Innate Pharma S.A. ADS | 11/30/2023 | 12/11/2023 | — | — | 57,420 | 3,423 | 16.77 | |
IPHA | Innate Pharma S.A. ADS | 11/15/2023 | 11/27/2023 | — | — | 60,030 | 29,105 | 2.06 | |
IPHA | Innate Pharma S.A. ADS | 10/31/2023 | 11/09/2023 | — | — | 63,748 | 8,094 | 7.88 | |
IPHA | Innate Pharma S.A. ADS | 10/13/2023 | 10/24/2023 | — | — | 57,186 | 9,607 | 5.95 | |
IPHA | Innate Pharma S.A. ADS | 09/29/2023 | 10/10/2023 | — | — | 62,467 | 20,934 | 2.98 |
In cerca di azioni più vendute allo scoperto?